About QT Sense
QT Sense is a Groningen-based startup spun out from the University Medical Center Groningen (UMCG) in February 2024, leveraging nanodiamond-based quantum sensing to detect changes in cellular activity at the single-cell level. The company secured €6 million in funding to advance its quantum sensing technology for disease diagnostics. QT Sense’s flagship product, Quantum Nuova, is a single-cell Nano-MRI platform designed to measure cellular activity with high precision, enabling early sepsis diagnostics and personalized cancer treatment. The company’s quantum technology has the potential to detect sepsis within seconds, significantly improving survival rates. QT Sense’s technology can understand diseases at a single-cell level, revolutionizing medical diagnostics through quantum sensing.
2025 Developments: Advancements in quantum sensing technology and applications continue throughout 2025. Focus on commercializing quantum sensors for defense, navigation, and medical applications. Ongoing collaborations with government agencies and industrial partners.
Company Information
- Founded: 2024
- Country: Netherlands
- Website: https://qtsense.nl
- Categories: quantum sensing
Related Companies
Explore other quantum computing companies in similar categories or regions.